Fundamental Data for PBIO

Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification.

# Employees: 27

Address: 14 Norfolk Avenue,South Easton,MA,USA

Phone: 508-230-1828

Fax: 508-230-1829

Website: www.pressurebiosciences.com

Email: ir@pressurebiosciences.com

Sector: Medical

Industry: MED INSTRUMENTS

Executive Officers

Wayne R. Fritzsche (Chmn.)

Richard T. Schumacher (Presi.; C.E.O.; Dir.)

Calvin A. Saravis Ph.D. (Dir.)

Donald J. Payne (Dir.)

Thomas P. Vogel (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 4/6/2010

Mean EPS (Next Qtr): ($0.37)

Mean EPS (Year): ($1.20)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 1

Shares Performance

Period	PBIO	Compare to S&P
YTD	52.38 %	26.10 %
4 Weeks	5.96 %	0.59 %
12 Weeks	18.45 %	10.30 %

Shares Information

Analyst Coverage: Y

Avg Volume: 6526

Shares Outstanding: 2M

Market Cap: $0.00B

52 Week High: $1.99

52 Week Low: $0.56

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 PBIO split by factor of 0.010

Earnings Performance

EPS Growth in Last Quarter: 10.26 %

EPS Growth in Last Year: 30.00 %

Sales Growth in Last Quarter: 17.41 %

Sales Growth in Last Quarter: 19.17 %

Financials

Qtr Book Value: $1.61

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 2.860